Query author contributions in Reactome
Reactome depends on collaboration between our curation team and outside experts to
assemble and peer-review its pathway modules. The integration of ORCID within Reactome
enables us to meet a key challenge with authoring, curating and reviewing biological
information by incentivizing and crediting the external experts that contribute their
expertise and time to the Reactome curation process. More information is available at
ORCID and Reactome.
If you have an ORCID ID that is not listed on this page, please
forward this information to us and we will update your Reactome pathway records.
Details on Person ASP-3026- resistant ALK mutants don't bind ASP-3026
| Class:Id | FailedReaction:9700646 |
| _displayName | ASP-3026- resistant ALK mutants don't bind ASP-3026 |
| _doRelease | TRUE |
| _timestamp | 2021-05-04 17:33:47 |
| authored | [InstanceEdit:9724129] Rothfels, Karen, 2021-03-22 |
| compartment | [Compartment:70101] cytosol [Compartment:876] plasma membrane |
| created | [InstanceEdit:9700663] Rothfels, Karen, 2020-09-16 |
| disease | [Disease:1500689] cancer |
| edited | [InstanceEdit:9725664] Rothfels, Karen, 2021-03-30 |
| entityFunctionalStatus | [EntityFunctionalStatus:9717334] loss_of_function of ASP3026-resistant ALK mutants [plasma membrane] |
| input | [ChemicalDrug:9702330] ASP-3026 [cytosol] [DefinedSet:9717270] ASP3026-resistant ALK mutants [plasma membrane] [Homo sapiens] |
| isChimeric | FALSE |
| literatureReference | [LiteratureReference:9717267] TKI sensitivity patterns of novel kinase-domain mutations suggest therapeutic opportunities for patients with resistant ALK+ tumors [LiteratureReference:9715259] Two novel ALK mutations mediate acquired resistance to the next-generation ALK inhibitor alectinib |
| modified | [InstanceEdit:9717338] Rothfels, Karen, 2021-03-08 [InstanceEdit:9724130] Rothfels, Karen, 2021-03-22 [InstanceEdit:9729590] Rothfels, Karen, 2021-04-30 [InstanceEdit:9729893] Rothfels, Karen, 2021-05-04 [InstanceEdit:9830342] Matthews, Lisa, 2023-03-08 |
| name | ASP-3026- resistant ALK mutants don't bind ASP-3026 |
| normalReaction |
|
| releaseDate | 2021-06-09 |
| reviewed | [InstanceEdit:9729891] Inghirami, Giorgio, 2021-05-04 |
| reviewStatus | [ReviewStatus:9821382] five stars |
| species | [Species:48887] Homo sapiens |
| stableIdentifier | [StableIdentifier:9700665] R-HSA-9700646.2 |
| summation | [Summation:9717314] The following ALK mutants are resistant to inhibition by ASP... |
| (hasEvent) | [Pathway:9717264] ASP-3026-resistant ALK mutants [Homo sapiens] |
|
[Change default viewing format]
|
No pathways have been reviewed or authored by ASP-3026- resistant ALK mutants don't bind ASP-3026 (9700646)